Gunilla Traberg Email

Director Sales . NATTOPHARMA ASA

Current Roles

Employees:
11
Revenue:
$1.7M
About
NattoPharma, the global Vitamin K2 R&D leader, continues to invest in true clinical science that further substantiates the bone and heart benefits of MenaQ7® Vitamin K2 as MK-7, the Expert Brand. The company delivers the most comprehensive K2 portfolio on the market, meeting manufacturers' and consumers' needs. • MenaQ7® Natural: chickpea-based fermentation • MenaQ7® PharmaPure: synthetic, natureidentical • MenaQ7® Natto: soy-based fermentation • MenaQ7®Full Spectrum: Holistic Vitamin K2 with MK-6, 7, 8 and 9 Further, NattoPharma helps manufacturers find the best solution for their Vitamin K2 applications, whether it be powder solutions, oils, water dispersible powders, liquid solutions, or the brand new CryoCap™, a microencapsulation technology that ensures MenaQ7® Vitamin K2 stability in even the most complex formulations. This solution-driven innovation ensures finished products deliver the proven benefits of MenaQ7® Vitamin K2, creating unparalleled value for brands and consumers. Backed by more than 19 published clinical trials, NattoPharma has the best clinically validated K2 on the market, and the only K2 with patents for cardiovascular health. NattoPharma: Our Science. Your Trust.
NATTOPHARMA ASA Address
Kirkeveien 59B
Oslo, null
Norway
NATTOPHARMA ASA Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.